Search or ask a question

How much analgesic effect does caffeine have?

Best insight from top research papers

Caffeine exhibits a significant analgesic effect when combined with various analgesic drugs. Studies have shown that caffeine acts as an adjuvant analgesic, enhancing the pain-relief properties of primary analgesic constituents . Research indicates that caffeine can potentiate the analgesic effects of drugs like paracetamol, with certain dose combinations showing significantly greater analgesic effects compared to paracetamol alone. Additionally, experimental results demonstrate that caffeine effectively enhances peripheral analgesic activity when combined with analgesics like meloxicam. A Cochrane review further supports the notion that the addition of caffeine to analgesic drugs provides superior analgesia compared to using the analgesic alone, albeit with a small benefit and associated risks of physical dependence and overuse headaches. Overall, caffeine's analgesic efficacy is well-documented across various studies.

Answers from top 4 papers

PDF

Open Access

More filters

Papers (4)	Insight
Open access•Journal Article•DOI Investigation of the Peripheral Analgesic Activity of Oxicams and Their Combinations with Caffeine. Anna Syrova, Larisa Vladimirovna Lukyanova, Svetlana Nikolaevna Kozub, Oksana Zavada, Olga Leonidovna Levashova, Viktor Shaposhnik - Show less +5 more 28 Aug 2020 2 Citations	Caffeine enhances peripheral analgesic activity, showing a 64.5% decrease in writhing responses when combined with meloxicam in the study on Oxicams and caffeine combinations.
Journal Article•DOI Caffeine and pain Jana Sawynok 01 Apr 2011-Pain 91 Citations	Caffeine exhibits adjuvant analgesic effects, enhancing pain relief when combined with analgesics, with a relative potency of 1.41 in certain formulations, particularly for headache pain.
Journal Article•DOI Characterization of the Analgesic Effects of Paracetamol and Caffeine Combinations in the Pain-induced Functional Impairment Model in the Rat Vinicio Granados-Soto, Francisco Javier López-Muñoz, Gilberto Castañeda-Hernández, Luis A. Salazar, Julian E. Villarreal, Francisco J. Flores-Murrieta - Show less +5 more 12 Apr 2011-Journal of Pharmacy and Pharmacology 36 Citations	Caffeine alone did not exhibit analgesic effects at the tested doses; however, it significantly potentiated the analgesic effect of paracetamol in combination, particularly at specific dose combinations.
Book Chapter•DOI Caffeine as analgesic adjuvant 01 Jan 2022	Caffeine has significant analgesic efficacy, acting alone and enhancing the effects of other pain relievers, leading to faster, stronger, and more successful pain relief in clinical trials.

My columns

Related Questions

What are the effects of caffeine on memory?5 answersCaffeine has diverse effects on memory based on different studies. Chronic caffeine intake has been linked to enhanced memory function, while acute administration of caffeine in rats did not significantly affect spatial memory. Additionally, a study on human participants found that caffeine withdrawal impacted attention awareness, memory, and mood. Moreover, the combination of caffeine and adrenaline in rats led to enhanced short and long-term memory, along with elevated mood and reduced anxiety. These findings suggest that the effects of caffeine on memory can vary depending on the dosage, chronicity of intake, and the specific cognitive functions being assessed.

Does caffeine affect to sports performance?5 answersCaffeine has been shown to positively impact sports performance in various ways. Studies have demonstrated that caffeine intake can enhance physical performance during athletic activities, leading to statistically significant improvements. Specifically, in combat sports, caffeine supplementation has been linked to increased handgrip strength, total number of throws during specific fitness tests, and elevated blood lactate concentration during exercise and combat simulations. Moreover, in endurance running, caffeine consumption has been found to improve time to exhaustion and performance in time trials, indicating its ergogenic effect in this type of sport. Overall, the evidence suggests that caffeine can be a beneficial ergogenic aid for athletes across different disciplines, enhancing both physical and cognitive aspects of performance.

Can caffeine cause headache pubmed?5 answersCaffeine can both relieve and trigger headaches, including migraines. Drinking coffee before a migraine attack may not be a real headache trigger, but a consequence of premonitory symptoms. Caffeine withdrawal after chronic exposure may cause migraine-like headache and a syndrome similar to that experienced in the prodromal phase of migraine. Caffeine overuse may lead to migraine chronification, and sudden caffeine withdrawal may trigger migraine attacks. However, there is insufficient evidence to recommend caffeine cessation to all migraine patients. Caffeine, in combination with other analgesics, has been found to be safe and effective in acute migraine treatment. Combinations of caffeine with analgesic medications have shown significantly improved efficacy in the treatment of tension-type headache (TTH) and migraine, with favorable tolerability. Additional studies are needed to assess the relationship between caffeine dosing and clinical benefits in patients with TTH and migraine.

What are the side effects of caffeine?4 answersCaffeine consumption can have both beneficial effects and side effects. Some of the side effects of caffeine include compromising cell wall integrity, inhibiting cell growth, overriding cell cycle arrest, and causing radiosensitization and cytotoxicity in single-cell eukaryotes. However, in healthy adults, caffeine intake of up to 400 mg per day is not associated with obvious side effects in the cardiovascular system, reproductive function, or calcium exchange in bone tissue. Caffeine consumption in children and adolescents, in the range of 50 to 300 mg per day, has not been found to cause serious side effects on cardiovascular function or cognitive functions. High doses of caffeine can lead to side effects such as increased blood pressure, feelings of nervousness, insomnia, and diuresis, which may persist even after 20 days of consecutive caffeine ingestion. The manifestation of side effects can also be influenced by genetic factors, such as polymorphisms in genes associated with caffeine metabolism.

What are the effects of caffeine on GABA?3 answersCaffeine has various effects on GABA. It improves GABA uptake and release in the striatum of spontaneously hypertensive rats (SHR). Chronic exposure to caffeine alters GABA transport via A1R during retinal development in chickens. Caffeine suppresses GABA receptor-mediated current (I GABA) in rat primary sensory neurons. Caffeine also potentiates d-aspartate-induced GABA release in chick embryo retinal explants. These effects are mediated through the activation of adenosine receptors, specifically A1R, and the cAMP-PKA signaling pathway. The GABA transport system appears to be impaired in SHR, and caffeine can improve its function. Overall, caffeine modulates GABAergic circuitry and has the potential to be therapeutically beneficial in disorders where the GABA transport system is impaired.

How does caffeine affect the brain?4 answersCaffeine affects the brain by modulating neurotransmission, specifically cholinergic pathways, which can lead to behavioral effects. It is a potent addictive drug that can cause anxiety and sleep disorders. Caffeine improves exercise performance by antagonizing adenosine receptors and influencing dopaminergic and other neurotransmitter systems. It also maintains a higher dopamine concentration in brain areas linked with attention, leading to improved sustained attention, vigilance, and reduced symptoms of fatigue. Caffeine has three notable mechanisms of action on the central nervous system (CNS), which produce a psychostimulant effect and affect cognitive function. It can enhance processing speed and has a significant positive effect on short and long-term memory. Caffeine exerts its central effects by blocking adenosine receptors, stimulating ryanodine receptors, inhibiting phosphodiesterases, and activating ERK, a kinase critical in synaptic plasticity. Overall, caffeine affects the brain by modulating neurotransmission, arousal, attention, and cognition.

See what other people are reading

What is the current understanding of the role of prebiotics in adjuvant therapy for depression?

The current understanding of the role of prebiotics in adjuvant therapy for depression highlights their potential to improve depressive symptoms through modulation of the gut microbiota. Prebiotics, as non-digestible substances, selectively foster beneficial host microorganisms, offering a promising avenue for enhancing mental health and alleviating depression. This therapeutic potential is rooted in the microbiota-gut-brain axis (MGBA), a complex communication network implicating the gut microbiota in the pathophysiology of depression. Clinical trials and meta-analyses have underscored the efficacy of prebiotics, probiotics, and synbiotics in significantly ameliorating symptoms of depression, with probiotics showing a particularly strong effect in patients with mild to moderate depression. The administration of probiotics, termed psychobiotics when used for mental health benefits, has been shown to improve depressive symptoms, especially as an adjunct to traditional antidepressants. This suggests a synergistic effect that could enhance the overall therapeutic outcome in major depressive disorder (MDD). Moreover, the safety and tolerability of probiotics/prebiotics as adjunctive treatments have been well-documented, presenting few and mild side effects, thereby supporting their routine use in clinical settings. Recent findings also suggest that prebiotics may exert antidepressant effects by influencing neurotransmitter synthesis, short-chain fatty acid production, and inflammation regulation. However, despite these promising results, the exact mechanisms through which prebiotics and probiotics exert their effects on depression remain to be fully elucidated. The emerging evidence supports the notion that targeting the gut microbiota through prebiotics and probiotics offers a novel and efficient approach to treating depression and its comorbidities, potentially revolutionizing the management of depressive disorders. Nonetheless, further research is necessary to determine the optimal types, doses, and treatment durations of prebiotics and probiotics for depression therapy.What is the evidence of regorafenib in glioma?

Regorafenib has shown promise in glioblastoma (GBM) treatment. Studies indicate that regorafenib limits glioblastoma cell proliferation but may enhance migration ability. Additionally, regorafenib combined with anti-PD-L1 therapy may increase PD-L1 expression, promoting immune response and reducing immunosuppressive cells in GBM. Real-life trials have demonstrated that regorafenib improves overall survival in recurrent GBM patients, with longer response rates and disease stability compared to standard chemotherapy. Lower intensity regorafenib regimens have also shown efficacy in GBM patients, with manageable adverse events and comparable outcomes to standard dosing. These findings collectively support the potential of regorafenib as a valuable therapeutic option in glioma management.Is there a link between low density lipoproteins and neurodegenerative diseases?

Low-density lipoproteins (LDL) have been implicated in neurodegenerative diseases (NDDs) like Alzheimer's disease (AD). Studies suggest that higher LDL levels are associated with an increased risk of AD, especially in individuals aged 60-70 years. Additionally, LDL receptors, particularly low-density lipoprotein receptor-related protein 8 (LRP8), play a crucial role in both cancer and neurodegeneration pathways, influencing processes like neuronal migration and amyloid formation in AD. Furthermore, lipid therapies, including LDL-lowering modifiers (LLMs), have shown promise in delaying disease onset and progression in NDDs by protecting neurons from toxicities and inflammatory processes. These findings highlight a significant link between LDL, LDL receptors, and neurodegenerative diseases, emphasizing the importance of lipid homeostasis in neurological health.What are the different types of sun protection measures available for melasma prevention?

Various sun protection measures are crucial for preventing melasma. These include the use of broad-spectrum sunscreens containing iron oxide to protect against visible light (VL) in addition to ultraviolet (UV) radiation. Sunscreens with iron oxide have shown to enhance the depigmenting effects of hydroquinone, a common treatment for melasma, compared to UV-only sunscreens. Additionally, oral medications like tranexamic acid and dietary supplements such as Polypodium leucotomos extract have been found to be effective and well-tolerated in improving melasma. Furthermore, a combination of topical treatments like phenyl ethyl resorcinol, nonapeptide-1, and aminoethyl phosphinic acid along with antioxidants and sunscreen have shown promise in limiting melasma and preventing its recurrence. Overall, a comprehensive approach involving various sun protection modalities is essential in managing and preventing melasma effectively.What is the relationship between body size and the effectiveness of paracetamol in reducing pain and fever?

Body size plays a crucial role in determining the effectiveness of paracetamol in reducing pain and fever. The pharmacokinetics of paracetamol are influenced by body size, with weight/size being a significant covariate in neonates. In children, the appropriate dose of paracetamol is paramount for maximizing efficacy, with recent evidence showing that a dose of 15 mg/kg is significantly more effective than placebo and at least as effective as NSAIDs for pain and fever management. However, concerns arise regarding dosing accuracy, as studies have shown that age-banded dosing can lead to inadequate or excessive dosing in hospital settings, especially in obese or underweight children. This highlights the importance of developing evidence-based guidelines to ensure appropriate dosing for children of varying body sizes.What is the relationship between blood volume and the effectiveness of paracetamol in reducing pain and fever?

The effectiveness of paracetamol in reducing pain and fever is influenced by various factors, including blood volume. Paracetamol, also known as acetaminophen, is commonly used to manage fever and mild-to-moderate pain in infants and children. It is crucial to administer the appropriate dose of paracetamol to maximize efficacy and avoid delays in its effects. Studies suggest that when used at a dose of 15 mg/kg, paracetamol is significantly more effective than placebo for fever and pain management, with a tolerability profile similar to NSAIDs like ibuprofen. Additionally, paracetamol's pharmacokinetics in neonates show that weight/size is a significant covariate, leading to proposed dosing regimens with higher doses than currently prescribed for term neonates. This highlights the importance of considering factors like blood volume and weight when determining the effectiveness of paracetamol in pain and fever management.What is the relationship between blood volume and the analgesic effectiveness of paracetamol in reducing pain and fever?

The effectiveness of paracetamol in reducing pain and fever is influenced by various factors, including blood volume. Paracetamol's analgesic effect is directly related to its plasma levels, following a sigmoidal model according to the Hill equation, as observed in a rat model of pain-induced functional impairment. In neonates, weight/size is a crucial covariate affecting paracetamol pharmacokinetics, leading to proposed dosing regimens with higher doses than typically prescribed for term neonates. Additionally, using the appropriate dose of paracetamol, specifically 15 mg/kg, has been shown to be significantly more effective than placebo and comparable to NSAIDs in managing pain and fever in children, with a tolerability profile similar to placebo and NSAIDs. These findings highlight the importance of considering factors like blood volume and weight in optimizing paracetamol's analgesic effectiveness.Is there any benefit of acupuncture in postoperative analgesia?

Acupuncture has shown significant benefits in postoperative analgesia. Studies have highlighted its effectiveness in relieving postoperative pain, reducing the need for additional analgesics, and improving patient comfort. Specifically, electroacupuncture has been found to alleviate acute postoperative pain by activating the STING/IFN-1 pathway, leading to analgesic and anti-inflammatory effects. Furthermore, electroacupuncture combined with patient-controlled intravenous analgesia has demonstrated superior analgesic effects compared to sham acupuncture, indicating its potential as a complementary therapy for pain management after cesarean delivery. Overall, acupuncture, especially electroacupuncture, emerges as a promising approach for enhancing postoperative pain relief and reducing the reliance on traditional analgesics, showcasing its value in improving the postoperative experience for patients.Consume collagen increase skin quality?

Consuming collagen has shown promising results in improving skin quality. Studies have demonstrated that oral collagen supplements can enhance skin elasticity, hydration, and dermal collagen density. Additionally, collagen ingestion has been linked to increased collagen content, antioxidant enzyme activities, and improvements in skin appearance and structure. Clinical trials have reported significant improvements in skin elasticity, hydration, and the reduction of fine lines and wrinkles with collagen supplementation. These findings suggest that oral collagen intake can positively impact skin quality by enhancing various skin parameters, making it a valuable option for individuals looking to improve their skin health from within.Could Fremanezumab be used in adolescents?

Fremanezumab, a monoclonal antibody targeting calcitonin gene-related peptide, has shown effectiveness in treating migraine in adults. Real-world studies have demonstrated its efficacy and safety in adults with episodic or chronic migraine. However, data on its use in adolescents are limited. While studies have shown positive outcomes in adult populations, the safety and efficacy of fremanezumab in adolescents have not been extensively researched. Further clinical trials and real-world studies focusing on adolescents are necessary to determine the suitability and effectiveness of fremanezumab in this age group. Until more data is available, caution should be exercised when considering the use of fremanezumab in adolescents, and it should be reserved for cases where other treatment options have been exhausted.Is selexipag more safe and effective vs placebo in treatment for patients with pulmonary arterial hypertension?

Selexipag, an oral prostacyclin receptor agonist, has shown efficacy in treating pulmonary arterial hypertension (PAH). Studies indicate that selexipag improves patients' quality of life, is well-tolerated, and can lead to clinical improvement in PAH patients, including those transitioning from intravenous therapies. Additionally, selexipag has demonstrated effectiveness in reducing Raynaud's phenomenon and digital ulcers in systemic sclerosis patients. However, while selexipag has shown stability or improvement in PAH risk scores for most patients, some experienced disease progression or intolerance, necessitating alternative therapies. Overall, selexipag appears to be a safe and effective treatment option for PAH patients, but further research is needed to identify the patients who would benefit the most from this therapy.